Two-Hour Seven-Sample Oral Glucose Tolerance Test and Meal Protocol

Minimal Model Assessment of β-Cell Responsivity and Insulin Sensitivity in Nondiabetic Individuals

  1. Chiara Dalla Man1,
  2. Marco Campioni1,
  3. Kenneth S. Polonsky2,
  4. Rita Basu3,
  5. Robert A. Rizza3,
  6. Gianna Toffolo1 and
  7. Claudio Cobelli1
  1. 1Department of Information Engineering, University of Padova, Padova, Italy
  2. 2Division of Endocrinology, Metabolism and Lipid Research, Washington University School of Medicine, St. Louis, Missouri
  3. 3Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota
  1. Address correspondence and reprint requests to Robert A. Rizza, MD, Mayo Clinic Rochester, 200 1st St., SW, Room 5-194 Joseph, Rochester, MN 55905. E-mail: rizza.robert{at}mayo.edu

Abstract

Highly informative yet simple protocols to assess insulin secretion and action would considerably enhance the quality of epidemiological and large-scale clinical trials. In an effort to develop such protocols, a 5-h, 11-sample oral glucose tolerance test (OGTT) was performed in 100 individuals and a 7-h, 21-sample meal in another 100. Plasma glucose, insulin, and C-peptide concentrations were measured. We show that virtually the same minimal model assessment of β-cell responsivity (dynamic [Φd] and static [Φs]), insulin sensitivity (Si), and disposition index (DI) can be obtained with a reduced seven-sample 2-h protocol: Φd, reduced versus full: 871.50 vs. 873.32, r = 0.98 in OGTT and 494.88 vs. 477.99 10−9, r = 0.91 in meal; Φs: 42.36 vs. 44.35, r = 0.88 in OGTT and 35.31 vs. 35.37 10−9 min−1, r = 0.90 in meal; Si: 24.33 vs. 22.77 10−5 dl · kg−1 · min−1 per pmol/l, r = 0.89 in OGTT and 19.03 vs. 19.77 10−5 dl · kg−1 · min−1 per pmol/l, r = 0.85 in meal; and DI: 1,282.26 vs. 1,273.23, r = 0.84 in OGTT and 726.92 vs. 776.97 10−14 dl · kg−1 · min−2 per pmol/l, r = 0.84 in meal. This reduced protocol will facilitate the study of insulin secretion and action under physiological conditions in nondiabetic humans.

Footnotes

    • Accepted August 18, 2005.
    • Received May 10, 2005.
« Previous | Next Article »Table of Contents